The Food and Drug Administration building is seen on Dec. 10, 2020, in Silver Spring, Md. (AP Photo/Manuel Balce Ceneta, File) WASHINGTON (AP) — For the first time, federal health officials are taking ...
Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers. HIMS has aggressively captured market share, often operating in a legal 'grey ...
Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...
Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...
Online telehealth company Hims and Hers Health HIMS.N is launching its weight-loss membership and treatment plans in the UK ...
For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs—including popular weight loss medications—as part of the Trump ...
Hims & Hers HealthHIMS is Wednesday's IBD Stock Of The Day. After returning to the IBD 50, Hims stock is making a second attempt at a breakout since late July. The telehealth giant announced its ...
Zacks Investment Research on MSN
Hims & Hers Expands Care Scope as Prescription Platforms Evolve
The renowned health and wellness platform, Hims & Hers Health, Inc.’s HIMS, business model links virtual consultations ...
One of largest U.S. telehealth providers expects to ride wave of exploding demand for weight-loss drug semaglutide when it ...
WASHINGTON – For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback